EXPLORE THIS STORY
FRANCE PERSPECTIVE
ELON MUSK LOSES LAWSUIT AGAINST OPENAI AFTER HIGH-STAKES SHOWDOWN WITH SAM ALTMAN
AI-generated content — Analyses are produced by artificial intelligence from press articles. They may contain errors or biases. Learn more
DOMINANT ANGLE
Paris views this verdict as confirmation that the internal squabbles of Silicon Valley pioneers cannot hinder an AI industry already too powerful to be defeated by one man, even the world's richest.
Dominant angle identified — does not reflect unanimity of this country’s media
ANALYSIS
Paris, May 18, 2026. After three weeks of hearings and less than two hours of deliberation, a nine-member California jury has ended one of the most publicized cases in recent tech history: Elon Musk has been dismissed from his entire lawsuit against OpenAI and its CEO Sam Altman. The reason: prescription. The billionaire had waited too long to file his lawsuit, filing it in 2024 outside of the legal deadlines.
The unanimous verdict was immediately confirmed by federal judge Yvonne Gonzalez Rogers, who presided over the Oakland court. She stated that she had 'a substantial volume of evidence' to support the jury's conclusions and hinted that any potential appeal by Musk would face significant obstacles, as the issue of prescription is a matter of fact.
At the heart of the dispute: the $38 million that Elon Musk had contributed to the OpenAI foundation when it was created in 2015. He accused Sam Altman, co-founder and CEO, as well as Microsoft, of diverting this non-profit organization to make it a commercial giant, enriching themselves in the process. Musk demanded that OpenAI return to its original status as a non-profit entity - a requirement that would have forced the startup to abandon its imminent IPO and sever ties with its main investors: Microsoft ($13 billion), Amazon, and Japanese SoftBank.
The trial has been a real soap opera for French media. Le Monde, RFI, and France 24 have all followed at least five tech billionaires as they testified in court. Sam Altman, the last to testify, described Musk as a man who craves 'absolute control,' refusing to let OpenAI's direction fall into other hands. Musk, on the other hand, presented himself at the opening on April 28 as a betrayed benefactor, a defender of humanity against an AI that had become a tool for private enrichment.
The jury did not have to rule on the substance: did Musk's donations really get diverted? The question remains unanswered in court. OpenAI, on the other hand, has been freed from a procedure that weighed on its growth ambitions. The company's commercial structure is now valued at $850 billion, and ChatGPT has 900 million weekly users. Its next IPO, now freed from this Damocles sword, is expected to be one of the major financial events of the year.
For French media, this outcome highlights the brutality of the rivalries that structure the global race for generative AI.
KEY POINTS
- Unanimous nine-member jury, deliberation of less than two hours: Musk dismissed for prescription, his 2024 lawsuit deemed outside of legal deadlines
- Elon Musk had contributed $38 million to OpenAI and demanded its return to a non-profit status, which would have blocked the IPO and severed ties with Microsoft ($13 billion), Amazon, and SoftBank
- OpenAI is valued at $850 billion, ChatGPT has 900 million weekly users - a judicial victory that secures the imminent IPO
COGNITIVE BIASES IDENTIFIED
Procedural-judicial framing: French coverage emphasizes prescription over the substance (mission diversion or not), leaving the central ethical question without in-depth treatment
Preference for the David-vs-Goliath narrative: French media valorize the soap opera of five tech billionaires (5 witnesses) over the systemic implications for AI governance
Low coverage of European regulatory implications: no article links the verdict to ongoing debates on AI regulation in Europe or the AI Act framework
SOURCES (3)
Le MondeCenter-left
RELIABLE
RFI
MEDIUMSTATE MEDIA
Does this analysis seem accurate?
